alexa Deborah Marriott | OMICS International
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Deborah Marriott

 Professor Division of Microbiology St. Vincent's Hospital Australia;    Adjunct Professor Department of Medical and Molecular Biosciences University of Technology Sydney Australia

Biography

Professor Debbie Marriott is a senior specialist at St. Vincent's hospital, Sydney, an adjunct professor at the University of Technology, Sydney, and a conjoint Associate Professor at the University of New South Wales. St. Vincent's Hospital Sydney is a unique institution as it has the largest HIV medicine unit in Australia, a lung and heart transplant unit and adult bone marrow transplantation.Prof. Marriott is recognised as an expert in fungal infections in immuno-compromised hosts and therapeutic drug monitoring and has over 150 publications in refereed journals. She has been an invited speaker at a number of international and national meetings. She is a founding member and past president of the Australasian Society for HIV Medicine and past state representative for the Royal Australasian College of Physicians. She is also a clinical representative on the NSW State TB Advisory Committee, an examiner for the Royal Australasian College of Physicians and she serves on a number of hospital committees. Recently she was elected President, Transplant Infectious Diseases (a section of The Transplant Society), and she is on the council of IATDMCT.

Research Interest

Prof. Marriott's clinical and research interest in fungal infections began soon after she diagnosed the first patient with HIV infection in Australia in 1983. She subsequently published on papers on the epidemiology and treatment of cryptococcal infection in normal, immuno-compromised and HIV-infected hosts and she remains interested and involved in research involving the treatment and epidemiology of fungal infections. Prof. Marriott developed a concept sheet for and later became a principal investigator of the Australian Candidaemia Study, a landmark study which was the first in the world to describe the epidemiology of candidaemia for an entire country, and it has resulted in over 10 publications in refereed journals and a similar number of conference presentations. Recently, in collaboration with MaCaS (the Malaysian candidaemia study group) she has completed a twelve month pilot study of candidaemia in Malaysia. She has a long-standing interest in infections in the Intensive Care unit, and more recently TDM of antimicrobial agents in critically ill patients, having undertaken daily rounds in the St. Vincent's Hospital ICU for nearly 30 years.

Publications
Top